About Sentrx
Sentrx is a company based in Little Falls (United States) founded in 1995 was acquired by C3i Solutions in April 2013. Sentrx operates in a competitive market with competitors including DrugCard, biologit, Beijing Dongxie Network, Advera Health and My Meds & Me, among others.
- Headquarter Little Falls, United States
- SectorsHealthcare
- Phone•••• ••••
- Website sentrx.com
- Social X Facebook
- Acquired by C3i Solutions (Apr 2013)
- Latest Funding Round$3M (USD), Debt – Conventional
Feb 2009
- InvestorsC3i Solutions
& 3 more
- Acquired byC3i Solutions
(Apr 2013)
Funding Insights of Sentrx
- Total Rounds 2
- Last Round Debt – Conventional — $3M
- Investors Count 3
All 2 funding rounds of Sentrx with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2009 | $3M | Debt – Conventional | – | – | |
| Jun 2006 | – | Unspecified | – | Argosy Capital |
4 investors in total: 4 institutional.
Investors in Sentrx
Sentrx has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include C3i Solutions, MMV Financial and Argosy Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Tech & Life-Sciences focused Growth stage Venture Debt Firm investing in North America | – | mmvf.com | Toronto, Canada | |
Argosy Capital is focused on investment management across multiple sectors. | 1990 | argosycapital.com | Wayne, United States | |
Provider of a growth equity firm for adaptive and personalized plans | – | edisonpartners.com | Princeton, United States | |
Customer engagement, medical information, and social media services are provided. | 1980 | c3isolutions.com | Horsham, United States |
Investor details for Sentrx
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Sentrx
4 dated milestones of Sentrx across 18 years, from founding to its latest funding, stage changes and deals.
- Founded Sentrx is founded.
- Funding First funding round.
- Funding Latest funding round, Debt – Conventional, of $3.0M.
- Exit Acquired by C3i Solutions.
Competitors of Sentrx
Sentrx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DrugCard, biologit, Beijing Dongxie Network, Advera Health and My Meds & Me, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| drug-card.io | 2020 | Tallinn, Estonia | $288,346 | – | Drug pharmacovigilance solutions are provided for pharmaceutical industries. | |
| biologit.com | 2021 | Dublin, Ireland | $1.09M | – | AI-based solutions for drug pharmacovigilance are provided. | |
| dongxitech.com | 2017 | Beijing, China | – | – | AI-based pharmacovigilance platform is developed for report analysis and monitoring. | |
| adverahealth.com | 2010 | Santa Rosa, United States | $4.7M | – | Provider of a SaaS based regulatory data analysis and pharmacovigilance platform for life science industry | |
| mymedsandme.com | 2012 | London, United Kingdom | $3.15M | 26 | Adverse events and product quality are captured for life sciences. | |
| novemberresearch.com | 2003 | Oakland, United States | – | 5 | Pharmacovigilance software and services are provided for medical vigilance. | |
| rxmxcorp.com | 2012 | Sydney, Australia | – | – | Delivers comprehensive medication management platforms for healthcare needs. | |
| ibluebutton.com | 2011 | Del Mar, United States | – | – | Mobile app for accessing health records from government programs and providers securely. | |
| insife.com | 2017 | Copenhagen, Denmark | – | – | Pharmacovigilance consulting services are provided to pharma, biotech, and agencies. |
Detailed competitors of Sentrx
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sentrx
Complete news archive for Sentrx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Sentrx
10 companies that operate in the same segment as Sentrx (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sentrx
Sentrx was founded in 1995 and raised its 1st funding round 11 years after it was founded.
Sentrx is headquartered in Little Falls, United States. It is registered at Little Falls, Minnesota, United States.
Sentrx, (acquired by Telerx in 2013) is a developer and provider of drug safety software solutions and hosting services for the Oracle Argus Safety Suite.The company offers solutions to biopharma organizations for improving safety, adverse event and medical affairs management. Their services range from adverse event data collection and management to safety system setup and hosting and also include primary and secondary research, trend analysis etc. Their proprietary clinical safety solutions include SaPh (a drug safety database management solution with tools and services to manage safety systems), CROPlus (a channel partner solution, offering flexible pharmacovigilance reporting packages) and UniPhi (a single source solution, which integrates all core Sentrx transactions and technology capabilities) which are integrated, customizable and scalable.
Sentrx's top competitors include biologit, My Meds & Me and DrugCard.
Sentrx has 4 investors. Key investors include C3i Solutions, MMV Financial, Argosy Capital, and Edison Partners.
Yes. Sentrx was acquired by C3i Solutions in April 2013.